The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Maternal Obesity Is Associated with Dysregulation of Metabolic, Vascular, and Inflammatory Pathways
Abstract
Obesity is increasing in prevalence worldwide and in all age groups. In nonpregnant individuals, obesity is associated with dyslipidemia; hyperinsulinemia; vascular dysfunction; and, more recently, low-grade chronic inflammation. However, whether such effects are sustained during pregnancy has been sparsely investigated but is important to establish, given the association of maternal obesity with numerous adverse metabolic and vascular consequences. We consecutively recruited 47 healthy women in the third trimester of pregnancy and divided the participants into 2 groups, lean [n = 24; median body mass index (BMI), 22.1 kg/m(2)] and obese (n = 23; median BMI, 31.0 kg/m(2)) around the median first trimester BMI. The age, parity, and smoking history were comparable in both groups. A detailed panel of metabolic and inflammatory parameters was measured and an in vivo assessment of endothelial-dependent and -independent microvascular function made using laser doppler imaging. Although low-density lipoprotein cholesterol and glycosylated hemoglobin were similar, fasting triglyceride concentrations were higher [2.70 (interquartile range, 2.3-3.21) vs. 2.20 (IQ range, 2.0-2.6) mmol/liter, P = 0.02] and high-density lipoprotein concentrations were lower [1.55 (IQ range, 1.1-1.7) vs. 1.72 (IQ range, 1.4-2.0) mmol/liter, P = 0.02] in the obese group. Leptin [55.6 (range, 45-64.4) ng/ml vs. 23.8 (range, 13.2-35.2) ng/ml, P < 0.0001] and fasting insulin [14.5 (range, 11.4-27.3) vs. 6.5 (range, 4.6-9.7) mU/liter, P < 0.0001] levels were more than double. Similarly, levels of inflammatory parameters, IL-6 [3.15 (range, 2.4-3.5) vs. 2.1 (range, 1.73-2.85) pg/ml, P = 0.003], and sensitive C-reactive protein [4.45 (range, 2.9-6.6) vs. 2.25 (range, 0.92-3.65) mg/ml, P = 0.0015] were also substantially elevated. Both endothelial-dependent and -independent vasodilatory responses were significantly reduced in the obese group (P = 0.0003 and P = 0.02, respectively, ANOVA) and systolic blood pressure was higher (P = 0.01). Metabolic factors, C-reactive protein (r = 0.289, P = 0.049), and insulin (r = 0.339, P = 0.02) were related inversely to endothelial-dependent function. These comprehensive data demonstrate that, as in nonpregnant obese individuals, obesity in pregnancy is associated not only with marked hyperinsulinemia (without necessarily glucose dysregulation) and dyslipidemia but also impaired endothelial function, higher blood pressure, and inflammatory up-regulation. Such a spectrum of risk factors may contribute to maternal complications in obese women and, as a result, influence fetal programming of adult vascular disease. Clearly, these data provide further rationale to examine the potential benefits of preconceptual weight loss and antenatal exercise.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Hubert, H. B., Feinleib, M., McNamara, P. M., & Castelli, W. P. (1983) · Circulation · doi:10.1161/01.cir.67.5.968 · Cited by 4,241
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,358
Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1
Mohamed-Ali, V., Goodrick, S., Rawesh, A., Katz, D. R., Miles, J. M., Yudkin, J. S., Klein, S., & Coppack, S. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4450 · Cited by 2,012
Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?
Yudkin, J. S., Kumari, M., Humphries, S. E., & Mohamed-Ali, V. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00463-3 · Cited by 1,775
Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., & Baron, A. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118709 · Cited by 1,687 · cited 1×
“This median value is similar to criteria used in previous studies (11).”
ResultNonadipose tissue production of leptin: Leptin as a novel placenta-derived hormone in humans
Masuzaki, H., Ogawa, Y., Sagawa, N., Hosoda, K., Matsumoto, T., Mise, H., Nishimura, H., Yoshimasa, Y., Tanaka, I., Mori, T., et al. (1997) · Nature Medicine · doi:10.1038/nm0997-1029 · Cited by 1,277
Regional adiposity and morbidity.
Kissebah, A. H., & Krakower, G. R. (1994) · Physiological Reviews · doi:10.1152/physrev.1994.74.4.761 · Cited by 1,130
Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus
Williams, S. B., Cusco, J. A., Roddy, M.-A., Johnstone, M. T., & Creager, M. A. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00522-6 · Cited by 1,014
Leptin: The Tale of an Obesity Gene
Caro, J. F., Sinha, M. K., Kolaczynski, J. W., Li Zhang, P., & Considine, R. V. (1996) · Diabetes · doi:10.2337/diab.45.11.1455 · Cited by 982
Cited by
Onuegbu, A. J., Olisekodiaka, J. M., Udo, J. U., Umeononihu, O., Amah, U. K., Okwara, J. E., & Atuegbu, C. (2015) · Medical Principles and Practice · doi:10.1159/000381778 · Cited by 2,044
Fain, J. N., Madan, A. K., Hiler, M. L., Cheema, P., & Bahouth, S. W. (2004) · Endocrinology · doi:10.1210/en.2003-1336 · Cited by 1,572
Catalano, P. M., & Shankar, K. (2017) · BMJ · doi:10.1136/bmj.j1 · Cited by 1,306
Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study
Villamor, E., & Cnattingius, S. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69473-7 · Cited by 756
Obesity in Pregnancy Stimulates Macrophage Accumulation and Inflammation in the Placenta
Challier, J. C., Basu, S., Bintein, T., Minium, J., Hotmire, K., Catalano, P. M., & Hauguel-de Mouzon, S. (2008) · Placenta · doi:10.1016/j.placenta.2007.12.010 · Cited by 712
Aune, D., Saugstad, O. D., Henriksen, T., & Tonstad, S. (2014) · JAMA · doi:10.1001/jama.2014.2269 · Cited by 631
Inflammation in maternal obesity and gestational diabetes mellitus
Pantham, P., Aye, I. L. M. H., & Powell, T. L. (2015) · Placenta · doi:10.1016/j.placenta.2015.04.006 · Cited by 582
Reynolds, R. M., Allan, K. M., Raja, E. A., Bhattacharya, S., McNeill, G., Hannaford, P. C., Sarwar, N., Lee, A. J., Bhattacharya, S., & Norman, J. E. (2013) · BMJ · doi:10.1136/bmj.f4539 · Cited by 571
Perinatal risk factors for childhood obesity and metabolic dysregulation
Catalano, P. M., Farrell, K., Thomas, A., Huston-Presley, L., Mencin, P., de Mouzon, S. H., & Amini, S. B. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27416 · Cited by 553
Maternal obesity and fetal metabolic programming: a fertile epigenetic soil
Heerwagen, M. J. R., Miller, M. R., Barbour, L. A., & Friedman, J. E. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00310.2010 · Cited by 518
Ness, R. B., & Sibai, B. M. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.07.049 · Cited by 462
Regulation of Nutrient Transport across the Placenta
Lager, S., & Powell, T. L. (2012) · Journal of Pregnancy · doi:10.1155/2012/179827 · Cited by 455
HAPO Study Cooperative Research Group (2010) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2009.02486.x · Cited by 395
Gestational Diabetes Induces Placental Genes for Chronic Stress and Inflammatory Pathways
Radaelli, T., Varastehpour, A., Catalano, P., & Hauguel-de Mouzon, S. (2003) · Diabetes · doi:10.2337/diabetes.52.12.2951 · Cited by 390
Maternal metabolism and obesity: modifiable determinants of pregnancy outcome
Nelson, S. M., Matthews, P., & Poston, L. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp050 · Cited by 370
The Human Placenta in Gestational Diabetes Mellitus
Desoye, G., & Hauguel-de Mouzon, S. (2007) · Diabetes Care · doi:10.2337/dc07-s203 · Cited by 355
Prepregnancy Obesity and Fetal Death: A Study Within the Danish National Birth Cohort
Nohr, E. A., Bech, B. H., Davies, M. J., Frydenberg, M., Henriksen, T. B., & Olsen, J. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000172422.81496.57 · Cited by 351
Luke, B., Brown, M. B., Stern, J. E., Missmer, S. A., Fujimoto, V. Y., Leach, R., & A SART Writing Group (2011) · Human Reproduction · doi:10.1093/humrep/deq306 · Cited by 345
Maternal Obesity, Metabolism, and Pregnancy Outcomes
King, J. C. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.24.012003.132249 · Cited by 341
The association of maternal obesity and diabetes with autism and other developmental disabilities
Li, M., Fallin, M. D., Riley, A., Landa, R., Walker, S. O., Silverstein, M., Caruso, D., Pearson, C., Kiang, S., Dahm, J. L., et al. (2016) · PEDIATRICS · doi:10.1542/peds.2015-2206 · Cited by 338
Fatty Acid Supply to the Human Fetus
Haggarty, P. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104742 · Cited by 333
Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic?
Catalano, P. M., & Hauguel-De Mouzon, S. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.11.039 · Cited by 329
Hendler, I., Goldenberg, R. L., Mercer, B. M., Iams, J. D., Meis, P. J., Moawad, A. H., MacPherson, C. A., Caritis, S. N., Miodovnik, M., Menard, K. M., et al. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.09.021 · Cited by 327
Maternal obesity during pregnancy and cardiovascular development and disease in the offspring
Gaillard, R. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-015-0085-7 · Cited by 322
“Obesity is associated with low-grade systemic inflammation and oxidative stress, also during pregnancy [116–118].”
BackgroundPoor uterine contractility in obese women
Zhang, J., Bricker, L., Wray, S., & Quenby, S. (2007) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.01233.x · Cited by 316
Jones, H. N., Woollett, L. A., Barbour, N., Prasad, P. D., Powell, T. L., & Jansson, T. (2009) · The FASEB Journal · doi:10.1096/fj.08-116889 · Cited by 310
Maternal obesity and neurodevelopmental and psychiatric disorders in offspring
Edlow, A. G. (2017) · Prenatal Diagnosis · doi:10.1002/pd.4932 · Cited by 308
Jansson, N., Rosario, F. J., Gaccioli, F., Lager, S., Jones, H. N., Roos, S., Jansson, T., & Powell, T. L. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2667 · Cited by 305
“In addition, fasting insulin is increased in obese pregnant women (26, 27).”
BackgroundThe Placenta Cytokine Network and Inflammatory Signals
Hauguel-de Mouzon, S., & Guerre-Millo, M. (2006) · Placenta · doi:10.1016/j.placenta.2005.08.009 · Cited by 294
Effects of obesity on women's reproduction and complications during pregnancy
Linné, Y. (2004) · Obesity Reviews · doi:10.1111/j.1467-789x.2004.00147.x · Cited by 289
Poston, L., Harthoorn, L. F., & van der Beek, E. M. (2011) · Pediatric Research · doi:10.1203/pdr.0b013e3182055ede · Cited by 282
Placental structure and inflammation in pregnancies associated with obesity
Roberts, K. A., Riley, S. C., Reynolds, R. M., Barr, S., Evans, M., Statham, A., Hor, K., Jabbour, H. N., Norman, J. E., & Denison, F. C. (2011) · Placenta · doi:10.1016/j.placenta.2010.12.023 · Cited by 282
Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy?
RODIE, V (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.01.038 · Cited by 275
Stewart, F. M., Freeman, D. J., Ramsay, J. E., Greer, I. A., Caslake, M., & Ferrell, W. R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2083 · Cited by 274
Self-citationThe risk of maternal obesity to the long‐term health of the offspring
O'Reilly, J. R., & Reynolds, R. M. (2013) · Clinical Endocrinology · doi:10.1111/cen.12055 · Cited by 273
Frias, A. E., Morgan, T. K., Evans, A. E., Rasanen, J., Oh, K. Y., Thornburg, K. L., & Grove, K. L. (2011) · Endocrinology · doi:10.1210/en.2010-1332 · Cited by 268
“However, obese human gravidae display metabolic, inflammatory, and vascular abnormalities, even when there are no associated medical conditions, suggesting that obesity by itself is a contributor to these adverse outcomes (34).”
BackgroundChristian, L. M., & Porter, K. (2014) · Cytokine · doi:10.1016/j.cyto.2014.06.018 · Cited by 268
Kanagalingam, M. G., Forouhi, N. G., Greer, I. A., & Sattar, N. (2005) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2005.00685.x · Cited by 256
Self-citationDevelopmental Origins of Obesity and the Metabolic Syndrome: The Role of Maternal Obesity
Armitage, J. A., Poston, L., & Taylor, P. D. (2008) · Frontiers of Hormone Research · doi:10.1159/000115355 · Cited by 252
White, C. L., Pistell, P. J., Purpera, M. N., Gupta, S., Fernandez-Kim, S.-O., Hise, T. L., Keller, J. N., Ingram, D. K., Morrison, C. D., & Bruce-Keller, A. J. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.04.002 · Cited by 245
“For example, IL-6 and placental inflammatory mediators are elevated with maternal obesity (Challier et al., 2008), (Ramsay et al., 2002), and maternal IL-6 levels are predictive of obesity in the neonatal offspring (Dahlgren et al., 2001).”
Maternal obesity and high-fat diet program offspring metabolic syndrome
Desai, M., Jellyman, J. K., Han, G., Beall, M., Lane, R. H., & Ross, M. G. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.03.025 · Cited by 244
Guénard, F., Deshaies, Y., Cianflone, K., Kral, J. G., Marceau, P., & Vohl, M.-C. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216959110 · Cited by 236
Placental Function in Maternal Obesity
Kelly, A. C., Powell, T. L., & Jansson, T. (2020) · Clinical Science · doi:10.1042/cs20190266 · Cited by 227
Obesity, pregnancy, inflammation, and vascular function
Denison, F. C., Roberts, K. A., Barr, S. M., & Norman, J. E. (2010) · Reproduction · doi:10.1530/rep-10-0074 · Cited by 221
Eriksson, J. G., Sandboge, S., Salonen, M. K., Kajantie, E., & Osmond, C. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.919728 · Cited by 213
Maternal adiposity—a determinant of perinatal and offspring outcomes?
Lawlor, D. A., Relton, C., Sattar, N., & Nelson, S. M. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.176 · Cited by 192
Self-citationDubé, E., Gravel, A., Martin, C., Desparois, G., Moussa, I., Ethier-Chiasson, M., Forest, J.-C., Giguère, Y., Masse, A., & Lafond, J. (2012) · Biology of Reproduction · doi:10.1095/biolreprod.111.098095 · Cited by 180
Gestational weight gain as a risk factor for hypertensive disorders of pregnancy
Macdonald-Wallis, C., Tilling, K., Fraser, A., Nelson, S. M., & Lawlor, D. A. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.05.042 · Cited by 167
Wallace, J. M., Horgan, G. W., & Bhattacharya, S. (2012) · Placenta · doi:10.1016/j.placenta.2012.05.006 · Cited by 163
Jadhav, S., Ferrell, W., Greer, I. A., Petrie, J. R., Cobbe, S. M., & Sattar, N. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.04.088 · Cited by 157
Self-citationObesity: a risk factor for preeclampsia
Walsh, S. W. (2007) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2007.09.003 · Cited by 155
The Role of Placental Nutrient Sensing in Maternal-Fetal Resource Allocation1
Díaz, P., Powell, T. L., & Jansson, T. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.114.121798 · Cited by 158
“For example, maternal nutrient restriction is typically associated with low circulating insulin, IGF-I, and leptin and elevated cortisol levels [30, 58], whereas conditions characterized by overnutrition, such as maternal obesity, often are associated with elevated serum insulin, IGFI, and leptin [19, 68].”
BackgroundTennant, P. W. G., Rankin, J., & Bell, R. (2011) · Human Reproduction · doi:10.1093/humrep/der052 · Cited by 134
Eriksson, J. G., Sandboge, S., Salonen, M., Kajantie, E., & Osmond, C. (2015) · Annals of Medicine · doi:10.3109/07853890.2015.1004360 · Cited by 129
Placental transport in response to altered maternal nutrition
Gaccioli, F., Lager, S., Powell, T. L., & Jansson, T. (2013) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174412000529 · Cited by 129
Rosario, F. J., Kanai, Y., Powell, T. L., & Jansson, T. (2015) · Obesity · doi:10.1002/oby.21165 · Cited by 128
“vated in the HF/HS pregnant mice in general agreement with the metabolic phenotype of the pregnant woman with obesity (10).”
Sattar, N., McConnachie, A., O’Reilly, D., Upton, M. N., Greer, I. A., Smith, G. D., & Watt, G. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000118277.41584.63 · Cited by 99
Self-citationLappas, M. (2014) · Metabolism · doi:10.1016/j.metabol.2013.10.001 · Cited by 97
Guideline No. 391-Pregnancy and Maternal Obesity Part 1: Pre-conception and Prenatal Care
Maxwell, C., Gaudet, L., Cassir, G., Nowik, C., McLeod, N. L., Jacob, C.-É., & Walker, M. (2019) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2019.03.026 · Cited by 96
Raipuria, M., Bahari, H., & Morris, M. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0120980 · Cited by 90
Gaccioli, F., White, V., Capobianco, E., Powell, T. L., Jawerbaum, A., & Jansson, T. (2013) · Biology of Reproduction · doi:10.1095/biolreprod.113.109702 · Cited by 76
“Inflammatory responses to pregnancy have been reported to be exaggerated in maternal obesity [43].”
BackgroundLamminpää, R., Vehviläinen-Julkunen, K., Gissler, M., Selander, T., & Heinonen, S. (2016) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2015.05.008 · Cited by 61
Using High-Dose Omega-3 Fatty Acid Supplements to Lower Triglyceride Levels in 10- to 19-Year-Olds
de Ferranti, S. D., Milliren, C. E., Denhoff, E. R., Steltz, S. K., Selamet Tierney, E. S., Feldman, H. A., & Osganian, S. K. (2014) · Clinical Pediatrics · doi:10.1177/0009922814528032 · Cited by 58
Kim, D. W., Glendining, K. A., Grattan, D. R., & Jasoni, C. L. (2016) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2016.06.005 · Cited by 50
Placental fatty acid transport in maternal obesity
Cetin, I., Parisi, F., Berti, C., Mandò, C., & Desoye, G. (2012) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174412000414 · Cited by 45
“When the metabolic environment of obese compared with non-obese women in late pregnancy was evaluated, the obese group showed more cases of dislipidemia with high levels of triglycerides and low concentrations of high-density lipoproteins, significant hyperleptinemia and hyperinsulinemia and elevated levels of inflamm…”
BackgroundWalsh, J. M., Mahony, R. M., Culliton, M., Foley, M. E., & McAuliffe, F. M. (2014) · Reproductive Sciences · doi:10.1177/1933719114525275 · Cited by 31
Haapanen, M. J., Vetrano, D. L., Mikkola, T. M., Calderón-Larrañaga, A., Dekhtyar, S., Kajantie, E., Eriksson, J. G., & von Bonsdorff, M. B. (2024) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(23)00231-3 · Cited by 27
Weight Loss Prior to Pregnancy and Early Gestational Glycemia: Prepare, a Randomized Clinical Trial
LeBlanc, E. S., Smith, N. X., Vesco, K. K., Hillier, T. A., & Stevens, V. J. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab547 · Cited by 26
Li, M.-F., Ke, J.-F., Ma, L., Wang, J.-W., Zhang, Z.-H., Li, J.-B., & Li, L.-X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.754406 · Cited by 20
Diagnosis of gestational diabetes: Evidence and pitfalls
Wong, T., Immanuel, J., Wong, V. W., Barnes, R., & Simmons, D. (2025) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2025.102069 · Cited by 4
Metadata
- Authors
- Ramsay, J. E., Ferrell, W. R., Crawford, L., Wallace, A. M., Greer, I. A., & Sattar, N.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-09
- Volume
- 87
- Issue
- 9
- Pages
- 4231-4237
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2135209333
- Cited by
- 659
- References
- 47
- FWCI
- 10.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.